First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients (original) (raw)
- Letter to the Editor
- Published: 27 September 2005
Molecular Psychiatry volume 11, pages 118–119 (2006)Cite this article
- 3608 Accesses
- 206 Citations
- Metrics details
Evidence suggests a deficit in NMDA receptor function is one underlying cause for schizophrenia.1 We tested this hypothesis using the highly selective single photon emission tomography (SPET) NMDA receptor tracer, [123I]CNS-1261. Significant reductions in relative NMDA receptor binding in left hippocampal medication-free, but not antipsychotic-treated, schizophrenic patients compared to healthy subjects were found.
[123I]CNS-1261 is an intrachannel NMDA receptor SPET probe that has been extensively developed with quantitative kinetic modeling methods in humans.2 Direct challenge with ketamine has revealed a displacement greater than test–retest in all brain regions (max 20%).3 We have recently reported the results of a study examining the impact of schizophrenia and antipsychotic treatment on [123I]CNS-1261 binding.4 Total volume of distribution (_V_T) was the main outcome measure. _V_T is a measure that is linearly proportional to _B_max/_K_d, but does not control for _f_1 and _f_2 (free fractions of tracer in plasma and in tissue, respectively). We now extend the analysis using normalized-to-cortex binding indices to evaluate regional NMDA receptor binding incorporating the effects of nonspecific binding.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Figure 1
References
- Coyle JT, Tsai G, Goff D . Ann NY Acad Sci 2003; 1003: 318–327.
- Erlandsson K, Bressan RA, Mulligan RS, Gunn RN, Cunningham VJ, Owens J et al. Nucl Med Biol 2003; 30: 441–454.
- Stone J, Erlandsson K, Arstad E, Bressan RA, Teneggi V, Ell PJ et al. Schizophrenia Bull 2005; 31 (2): 446.
- Bressan RA, Erlandsson K, Stone JM, Mulligan RS, Krystal JH, Ell PJ et al. Biol Psychiatry 2005; 58 (1): 41–46.
- Friston K, Holmes A, Worsley K, Poline J, Frith C, Frackowiak RSJ . Human Brain Mapping 1995; 2: 189–210.
- Lancaster JL, Woldorff MG, Parsons LM, Liotti M, Freitas CS, Rainey L et al. Human Brain Mapping 2000; 10: 120–131.
- Takeuchi R, Yonekura Y, Matsuda H, Konishi J . Eur J Nucl Med Mol Imaging 2002; 29: 331–341.
Acknowledgements
RA Bressan was financially supported by research grants from CAPES (Brazil), Janssen Pharmaceutica Inc., and Sanofi-Syntelabo, LS Pilowsky was financially supported by a UK Medical Research Council (MRC) Senior Clinical Research Fellowship. K Erlandsson and RS Mulligan were financially supported on a UK MRC Senior clinical research fellowship. JH Krystal was funded by NIH: KO5 AA 014906-02, Department of Veterans Affairs: VA Alcohol Research Center, VA Schizophrenia Biological Research Center. LSP, RAB, JMS, KE, RSM, PJE contributed to the study execution, analysis and writing up of the data. JHK contributed to the interpretation and writing up of the data.
Author information
Authors and Affiliations
- King's College London, Institute of Psychiatry, London, UK
L S Pilowsky, R A Bressan & J M Stone - Institute of Nuclear Medicine, University College London, London, UK
L S Pilowsky, K Erlandsson, R S Mulligan & P J Ell - Department of Psychiatry, Yale University, New Haven, CT, USA
J H Krystal - VA Connecticut Healthcare System, West Haven, CT, USA
J H Krystal
Authors
- L S Pilowsky
You can also search for this author inPubMed Google Scholar - R A Bressan
You can also search for this author inPubMed Google Scholar - J M Stone
You can also search for this author inPubMed Google Scholar - K Erlandsson
You can also search for this author inPubMed Google Scholar - R S Mulligan
You can also search for this author inPubMed Google Scholar - J H Krystal
You can also search for this author inPubMed Google Scholar - P J Ell
You can also search for this author inPubMed Google Scholar
Rights and permissions
About this article
Cite this article
Pilowsky, L., Bressan, R., Stone, J. et al. First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients.Mol Psychiatry 11, 118–119 (2006). https://doi.org/10.1038/sj.mp.4001751
- Published: 27 September 2005
- Issue Date: 01 February 2006
- DOI: https://doi.org/10.1038/sj.mp.4001751